Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlorphenamine 50mg/5ml oral solution
0304010G0AAALAL
|
Chlorphenamine maleate | Chlorphenamine maleate | Respiratory System | No data available |
|
Cinqaero 100mg/10ml concentrate for inf vials
0304020Z0BBAAAA
|
Cinqaero | Reslizumab | Respiratory System | No data available |
|
Cinqaero 25mg/2.5ml concentrate for inf vials
0304020Z0BBABAB
|
Cinqaero | Reslizumab | Respiratory System | No data available |
|
Cinryze 500unit inj vials
0304030F0BFAAAA
|
Cinryze | C1-Esterase inhibitor | Respiratory System | No data available |
|
Citric acid 20mg/Ipecac liq ext 10microL/5ml soln
0309020AGAAAAAA
|
Citric acid monohydrate/ipecacuanha | Citric acid monohydrate/ipecacuanha | Respiratory System | No data available |
|
Clarityn 5mg/5ml syrup
0304010D0BBABAB
|
Clarityn | Loratadine | Respiratory System | No data available |
|
Clarityn Allergy 1mg/ml syrup
0304010D0BBAFAF
|
Clarityn | Loratadine | Respiratory System | No data available |
|
Clarityn Allergy 5mg/5ml syrup
0304010D0BBADAB
|
Clarityn | Loratadine | Respiratory System | No data available |
|
Clemastine 500micrograms/5ml oral solution sugar free
0304010H0AAAAAA
|
Clemastine fumarate | Clemastine fumarate | Respiratory System | No data available |
|
Codeine 3mg/5ml linctus paediatric
0309010C0AAACAC
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | No data available |
|
Codeine 3mg/5ml linctus paediatric sugar free
0309010C0AAAEAE
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | No data available |
|
Combivent inhaler
0301040R0BBAAAA
|
Combivent | Salbutamol | Respiratory System | No data available |
|
Contac 400 modified-release capsules
0304010ADBBAAAA
|
Contac (Antihistamine) | Phenylprop hydrochloride/chlorphenamine maleate | Respiratory System | No data available |
|
Contac Non Drowsy 12 Hour Relief 120mg modified-release caps
0310000N0BQAAAA
|
Contac (Pseudoephedrine hydrochloride) | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Contac Non Drowsy Dual Relief tablets
0310000N0BXAAAW
|
Contac (Paracetamol/pseudoephedrine) | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Cough Nurse Night Time Liquid
0309020ABBBAAAA
|
Cough Nurse | Diphenhydramine hydrochloride/pholcodine | Respiratory System | No data available |
|
Covonia Hot Dose Cough & Cold syrup
0309020R0BDABAB
|
Covonia (Dextromethorphan/diphenhydramine) | Dextromethorphan hydrobrom compound prepartions | Respiratory System | No data available |
|
Covonia Original Bronchial Balsam oral solution
0309010L0BFABAV
|
Covonia | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Covonia Vapour Drops
030800000BDBNA0
|
Proprietary compound preparation BNF 0308000 | Other aromatic inhalation preparations | Respiratory System | No data available |
|
Cromogen 20mg/2ml nebuliser liquid Steri-Neb unit dose vials
0303010Q0BFACAE
|
Cromogen | Sodium cromoglicate | Respiratory System | No data available |
|
Cromogen 5mg/dose Easi-Breathe inhaler
0303010Q0BFADAH
|
Cromogen | Sodium cromoglicate | Respiratory System | No data available |
|
Cromogen 5mg/dose inhaler
0303010Q0BFABAB
|
Cromogen | Sodium cromoglicate | Respiratory System | No data available |
|
Cromosol 20mg/2ml nebuliser liquid unit dose vials
0303010Q0BHAAAE
|
Cromosol | Sodium cromoglicate | Respiratory System | No data available |
|
Cyproheptadine 2mg/5ml oral liquid
0304010K0AAADAD
|
Cyproheptadine hydrochloride | Cyproheptadine hydrochloride | Respiratory System | No data available |
|
Cyproheptadine 4mg/5ml oral liquid
0304010K0AAAFAF
|
Cyproheptadine hydrochloride | Cyproheptadine hydrochloride | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.